Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Apixaban vs aspirin vs enoxaparin thromboprophylaxis in newly diagnosed multiple myeloma
2015-002668-18Phase 4Terminated
- Sponsor
- King's College Hospital
- Start
- Nov 2015
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial in multiple myeloma (MM) comparing Apixaban arm, Aspirin arm and Enoxaparin arm (3 arms). Started Nov 2015; status: terminated.
02
Drugs
apixabanaspirinenoxaparin
03
Conditions
multiple myeloma (MM)
Beyond the preview
Go deeper on 2015-002668-18.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2015-002668-18.